^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CD34 positive

i
Other names: CD34, CD34 Molecule, CD34 Antigen, Hematopoietic Progenitor Cell Antigen CD34
Entrez ID:
Related biomarkers:
12d
Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis. (PubMed, J Dermatol)
Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.
Journal
|
CD34 (CD34 molecule) • LZTR1 (Leucine Zipper Like Transcription Regulator 1)
|
CD34 positive
14d
Superficial Papular Neuroma: Two Cases of a Distinctive Dermal Neoplasm. (PubMed, Am J Dermatopathol)
The nerve-like structures in this study were occasionally surrounded by a thin rim of CD34 positivity, with no epithelial membrane antigen staining, similar to normal sensory neurons. Superficial papular neuroma are rare benign neoplasms with no reports of recurrence, even when incompletely excised.
Journal
|
CD34 (CD34 molecule) • SOX10 (SRY-Box 10)
|
CD34 positive
18d
Periductal stromal tumor of the breast; Can we expect the diagnosis? A case report and literature review. (PubMed, Int J Surg Case Rep)
Periductal stromal tumor is a rare breast neoplasm with potentially benign behavior. Complete excision is the standard management approach, which not only reveals the final diagnosis but may also help reduce the rates of local recurrence and malignant transformation.
Review • Journal • Stroma
|
CD34 (CD34 molecule)
|
CD34 positive
24d
ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coronavirus infection and retained the persistence of viral proteins in the lung tissue (PubMed, Arkh Patol)
We found an increase in the number of CSCs with expression of ALDH1, CD133 and CD34 in lung adenocarcinoma in patients with new coronavirus infection. Increased number of ALDH1+, CD133+ CD34+ CSCs in tumor tissue enhance the metastatic potential of lung adenocarcinoma. The Nucleocapsid and Spike proteins of SARS-CoV2 virus are detectable in lung tissue from patients with new coronavirus infection, both in adenocarcinoma cells, CSCs, and in type II pneumocytes, macrophages, and endothelial cells, suggesting prolonged persistence of the virus proteins and probably the virus.
Journal • Cancer stem
|
CD34 (CD34 molecule) • ALDH1A1 (Aldehyde Dehydrogenase 1 Family Member A1)
|
CD33 positive • CD34 positive • CD133 expression • CD133 positive
24d
JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-β. (PubMed, J Cell Mol Med)
In conclusion, we show a JAK2-dependent down regulation of SHP-1 in MPN patients' cells which is related to their resistance to the antiproliferative effect of TGF-β. This may participate in the clonal selection of cancer cells in MPNs.
Journal
|
JAK2 (Janus kinase 2) • CD34 (CD34 molecule) • TGFB1 (Transforming Growth Factor Beta 1)
|
JAK2 V617F • CD34 positive
1m
Immunophenotypic properties association of CLL and ALL patient cells by flow cytometry analysis. (PubMed, J Taibah Univ Med Sci)
In patients with CLL, there was a strong positive correlation between the number of CD19-positive cells and the number of cells expressing CD5, CD20, CD23, and CD200. Additionally, in patients with ALL, there was a positive correlation of CD79 and CD99 with the number of CD19-positive cells.
Journal
|
CD20 (Membrane Spanning 4-Domains A1) • CD34 (CD34 molecule) • CD5 (CD5 Molecule) • CD200 (CD200 Molecule) • CD99 (CD99 Molecule) • FCER2 (Fc Fragment Of IgE Receptor II)
|
CD19 positive • CD20 expression • CD34 positive
1m
S100 and CD34 positive spindle cell tumors of the uterine cervix with EGFR mutation: a hitherto unrecognized neoplasm phenotypically and epigenetically overlapping with "NTRK-rearranged spindle cell neoplasms" of the uterus. (PubMed, Virchows Arch)
The patient in case 2 had no other known tumors at the time of diagnosis, but no follow-up is available. We believe the reported cases represent a hitherto unrecognized variant of "NTRK-rearranged spindle cell neoplasms" of the uterine cervix with novel EGFR mutations.
Journal
|
EGFR (Epidermal growth factor receptor) • BRAF (B-raf proto-oncogene) • RET (Ret Proto-Oncogene) • NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1) • NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3) • NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2) • TNFRSF8 (TNF Receptor Superfamily Member 8) • CD34 (CD34 molecule) • SOX10 (SRY-Box 10) • NTRK (Neurotrophic receptor tyrosine kinase)
|
EGFR mutation • BRAF mutation • NTRK1 fusion • NTRK3 fusion • NTRK2 fusion • RET fusion • TNFRSF8 expression • EGFR exon 20 mutation • CD34 positive
1m
PRAME expression in fibrosarcomatous dermatofibrosarcoma protuberans. (PubMed, Sci Rep)
Double staining of CD34 and PRAME revealed that PRAME-positive and CD34-positive areas did not overlap. This is the largest study to examine PRAME expression in FS-DFSP, and it confirmed the usefulness of PRAME in diagnosing this condition.
Journal • IO biomarker
|
CD34 (CD34 molecule) • PRAME (Preferentially Expressed Antigen In Melanoma)
|
CD34 positive • PRAME expression
1m
Central nervous tissue in ovarian mature teratoma: A neuropathological study of 101 resected tumors. (PubMed, Neuropathology)
The principal pathologic findings in the CNS tissue from ovarian mature teratomas were as follows: (i) CNS tissue tended to form a relatively thin, undulating, plate-like structure that comprised the walls or septa of cystic tumors; (ii) most neurons were small or medium sized, and no CD34-positive "ramifying cells" were observed; (iii) cytoplasmic processes of some astrocytes closely surrounded the walls of capillaries, suggesting formation of a blood-brain barrier; (iv) some ependymal cells exhibited a columnar shape and showed a pseudostratified arrangement, and these cells extended thick basal cytoplasmic processes into the neuropil; (v) a few choroid plexus epithelial cells showed melanin deposition, tubular transformation, or oncocytic changes; (vi) hamartoma-like hyperplasia of arachnoid cells was noted beneath skin tissue; (vii) some CNS tissue showed formation of cerebral cortical structures exhibiting "gyration" with incompletely layered structures, and disruption of the glia limitans with spillage of cortical tissue into the "subarachnoid" space was also observed; and (viii) in the well-formed cerebellar cortex, dendrites of Purkinje cells exhibited varied dysmorphic changes. These neuropathologic observations should lead to a deeper understanding of the pathogenesis of various lesions in the brain.
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
1m
Superficial CD34 Positive Fibroblastic Tumor: A Rare Entity With Cytological and Histopathological Correlation. (PubMed, Diagn Cytopathol)
We present a case of a young male aged 27 years who presented to the General Surgery OPD with a history of slow-growing mass over right thigh for 7 years. FNAC and subsequent histopathological examination revealed a diagnosis of SPFT.
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
2ms
Role of CD34 in calcification of human aortic valve interstitial cells from patients with aortic valve stenosis. (PubMed, J Pharmacol Sci)
These results suggest one possibility that CD34 is an inhibitory regulator of valve calcification. Furthermore, TNF-α- and IL-1β-induced CD34 downregulation in HAVICs contributes to HAVIC calcification by downregulating TNX protein expression.
Journal
|
KDR (Kinase insert domain receptor) • TNFA (Tumor Necrosis Factor-Alpha) • CD73 (5'-Nucleotidase Ecto) • CD34 (CD34 molecule) • TGFB1 (Transforming Growth Factor Beta 1) • IL1B (Interleukin 1, beta)
|
CD34 positive
2ms
CD34-positive spindle cell tumour with FGFR1::TACC1 fusion: entity of uncertain behaviour (ECP 2024)
In this particular case, the immunohistochemical and molecular results support a diagnosis of a fibroblastic/myofibroblastic tumour of uncertain behaviour. Notably, there have been no reported cases in the literature of a soft tissue tumour harboring FGFR1::TACC1 fusion as a primary occurrence in this anatomical location. The patient remains in good health without any evidence of disease recurrence at the 5-month follow-up post-surgical intervention.
ALK (Anaplastic lymphoma kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • FGFR1 (Fibroblast growth factor receptor 1) • MDM2 (E3 ubiquitin protein ligase) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CD34 (CD34 molecule) • MME (Membrane Metalloendopeptidase) • COL1A1 (Collagen Type I Alpha 1 Chain) • NTRK (Neurotrophic receptor tyrosine kinase) • STAT6 (Signal transducer and activator of transcription 6) • SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex) • TACC1 (Transforming Acidic Coiled-Coil Containing Protein 1)
|
MDM2 amplification • FGFR1 fusion • CD34 positive
|
Archer® FusionPlex® Sarcoma kit • FusionPlex® Dx
2ms
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
2ms
Update on cutaneous mesenchymal tumors in the 5th edition of WHO classification of skin tumors with an emphasis on new fusion-associated neoplasms. (PubMed, Virchows Arch)
These specifically include three novel cutaneous mesenchymal tumors with melanocytic differentiation, and rearrangements of the CRTC1::TRIM11, ACTIN::MITF, and MITF::CREM genes as well as EWSR1::SMAD3-rearranged fibroblastic tumors, superficial CD34-positive fibroblastic tumors, and NTRK-rearranged spindle cell neoplasms. Some of the other most important changes will be briefly mentioned as well.
Review • Journal
|
EWSR1 (EWS RNA Binding Protein 1) • CD34 (CD34 molecule) • NTRK (Neurotrophic receptor tyrosine kinase) • CREM (CAMP Responsive Element Modulator) • MITF (Melanocyte Inducing Transcription Factor) • CRTC1 (CREB Regulated Transcription Coactivator 1) • SMAD3 (SMAD Family Member 3)
|
CD34 positive
2ms
Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. (PubMed, Am J Clin Pathol)
The MCs in AML-MC cases are characterized by dim CD45, low side scatter, CD34 and CD123 positivity, and uniform and increased CD38 expression. Flow cytometry is an excellent tool for identifying AML-MC cases.
Journal • IO biomarker
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD38 (CD38 Molecule) • CD123 (Interleukin 3 Receptor Subunit Alpha) • IL2RA (Interleukin 2 receptor, alpha) • CD34 (CD34 molecule) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • NCAM1 (Neural cell adhesion molecule 1) • IL3RA (Interleukin 3 Receptor Subunit Alpha) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
CD38 expression • CD123 positive • NCAM1 expression • CD34 positive
6ms
MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio. (PubMed, Leuk Res)
Using double-labeling for Bcl-2 and Ki-67 it could be shown that besides blast cells with a mutually exclusive Ki-67 and Bcl-2 expression, also blast cells concurrently exhibiting anti-apoptotic and proliferative marker expression were found. Integrating these two dynamic markers into MDS and AML diagnostic workups may enable informed conclusions about their biological behavior, facilitating individualized therapy decisions for patients.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CD34 (CD34 molecule)
|
BCL2 expression • CD34 positive
6ms
Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia. (PubMed, Eur Rev Med Pharmacol Sci)
A higher positive rate of bone marrow CD34 expression in children with B-ALL is associated with a favorable prognosis. Children with negative CD34 expression are relatively more prone to MRD and tumor relapse after chemotherapy.
Retrospective data • Journal • IO biomarker
|
CD20 (Membrane Spanning 4-Domains A1) • CD38 (CD38 Molecule) • CD22 (CD22 Molecule) • CD33 (CD33 Molecule) • CD34 (CD34 molecule) • PBX1 (PBX Homeobox 1) • CD79A (CD79a Molecule) • MME (Membrane Metalloendopeptidase) • ANPEP (Alanyl Aminopeptidase, Membrane)
|
CD34 positive • MLL-AF4 fusion
6ms
Hepatic hemangioma in a simple liver cyst mimicking biliary cystic neoplasm. (PubMed, Surg Case Rep)
Cavernous hemangiomas mimicking well-enhanced mural nodules can arise from simple liver cysts. In less malignant cases, laparoscopic biopsy or percutaneous targeted biopsy of the mural nodules, together with needle ablation, may be recommended to avoid unnecessary surgery.
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • CD34 (CD34 molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1)
|
CD34 positive
7ms
Mesenchymal skin tumors - Novel entities in the 5th edition of WHO classification of skin tumors. (PubMed, Cesk Patol)
In addition, EWSR1::SMAD3-rearranged fibroblastic tumors, superficial CD34-positive fibroblastic tumors, and NTRK-rearranged spindle cell neoplasms were newly included. Of the other changes, only the most important ones will be briefly mentioned.
Review • Journal
|
EWSR1 (EWS RNA Binding Protein 1) • CD34 (CD34 molecule) • NTRK (Neurotrophic receptor tyrosine kinase) • CREM (CAMP Responsive Element Modulator) • MITF (Melanocyte Inducing Transcription Factor) • CRTC1 (CREB Regulated Transcription Coactivator 1) • SMAD3 (SMAD Family Member 3)
|
CD34 positive
7ms
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality. (PubMed, Transfusion)
We found no difference in survival, relapse, or GVHD incidence or severity in patients receiving CD34+ doses above prior cutoffs reported in the literature. These data do not support the routine use of graft CD34+ dose reduction.
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
7ms
Comparison of cytomorphology and histomorphology in myelodysplastic syndromes. (PubMed, Front Oncol)
Histopathology provided additional diagnostic and prognostic information with high diagnostic and prognostic significance, such as fibrosis. Likewise, histopathology allowed more reliable estimation of bone marrow cellularity.
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
7ms
Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress. (PubMed, J Cell Mol Med)
BTZ also increased mitochondrial superoxide levels in KG-1a cells, and BTZ-induced apoptosis was partially prevented by pretreatment with the antioxidant N-acetylcysteine, indicating that BTZ induces oxidative stress-mediated apoptosis in KG-1a cells. At a dosage of 0.1 mg/kg every other day for 2 weeks, BTZ significantly reduced the percentage of hCD45-positive cells in the bone marrow and peripheral blood of NSG mice engrafted with KG-1a cells with tolerable toxicity. Taken together, these data indicate that the anti-LSC potential of BTZ appears to be an important strategy for AML treatment.
Journal
|
CD123 (Interleukin 3 Receptor Subunit Alpha) • CD34 (CD34 molecule) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • CASP3 (Caspase 3) • IL3RA (Interleukin 3 Receptor Subunit Alpha)
|
CD123 positive • CD34 positive • IL3RA positive
|
bortezomib
7ms
The Correlation between VEGF and CD34 Protein Marker and Pyogenic Granuloma. (PubMed, Clin Lab)
The results suggest the role of suchbiomarkers in the oral pyogenic granuloma pathogenesis, and it appears that CD34 and VEGF are valuable biomarkers in evaluating vascular and inflammatory diseases like pyogenic granuloma.
Journal
|
VEGFA (Vascular endothelial growth factor A) • CD34 (CD34 molecule)
|
CD34 positive
8ms
Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation. (PubMed, J Thorac Dis)
Multivariate analysis revealed that high RMV was an independent negative predictor of PFS (hazard ratio, 3.21; 95% CI: 1.18-8.76, P=0.022). High RMV may critically affect EGFR-TKI resistance in patients with NSCLC and EGFR mutations.
Journal
|
CD34 (CD34 molecule)
|
EGFR mutation • CD34 positive
8ms
Pulmonary Epithelioid Hemangioendothelioma Requiring Differentiation from Metastatic Lung Tumor:Report of a Case (PubMed, Kyobu Geka)
When new nodules are noted on routine CT scans of other malignancies, it is essencial to make a pathological diagnosis, bearing in mind that pulmonary nodules can arise from a variety of causes.
Journal • Metastases
|
CD34 (CD34 molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1)
|
CD34 positive
8ms
Upper abdominal pain in a young woman treated by endoscopic submucosal dissection. (PubMed, Rev Esp Enferm Dig)
Immunohistochemical analysis of the spindle cells showed CD34 was positive and CD117, S100, DOG-1, SMA, Desmin were negative. The patient was diagnosed as gastric inflammatory fibroid polyp (IFP) and no symptoms was observed in 12 months follow-up.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD34 (CD34 molecule) • ANO1 (Anoctamin 1)
|
CD34 positive
8ms
Epigenetic control over cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia. (PubMed, Blood)
Pharmacological support of PHF8 phosphorylation significantly impairs growth of primary AML patient samples. These findings provide novel opportunities for harnessing the cell-intrinsic immune response in the development of immunotherapeutic strategies against AML.
Journal • IO biomarker • Epigenetic controller
|
CD34 (CD34 molecule)
|
CD34 positive
9ms
Intramuscular Hybrid Nerve Sheath Tumor of the Thigh: Case Report and Literature Review. (PubMed, In Vivo)
Although extremely rare, HNST should be included in the extended differential diagnosis of a well-circumscribed, intramuscular soft-tissue mass in the extremities, particularly in young and early middle-aged adults.
Review • Journal
|
CD34 (CD34 molecule)
|
CD34 positive
9ms
Lipoblastoma of the lip. (PubMed, Indian J Pathol Microbiol)
Here, we report one of the first cases of lipoblastoma of lip in a 10-year-old boy with atypical immunohistochemical features and the need for thorough clinical and histopathological evaluation of cases with atypical findings. The novel pathogenetic mechanism of lipoblastoma from the cluster of differentiation 34-positive (CD34+) stem cells has also been discussed.
Journal
|
CD34 (CD34 molecule) • PLAG1 (PLAG1 Zinc Finger)
|
CD34 positive
9ms
A unique case of epithelioid sarcoma involving the mandibular alveolar mucosa. (PubMed, Oral Surg Oral Med Oral Pathol Oral Radiol)
To date, to our knowledge, only 11 instances of head and neck ES have been reported in the literature. Our case deals with the diagnosis of intraoral ES in a 55-year-old female patient, probably the first one to involve the mandibular mucosa, based on relevant clinical-radiologic-pathologic-immunohistochemical findings.
Clinical • Observational data • Retrospective data • Review • Clinical Trial,Phase I • Clinical Trial,Phase II • Journal
|
SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) • CD34 (CD34 molecule) • VIM (Vimentin)
|
CD34 positive
9ms
EXPRESS: GDF11 Level and Its Effect on Prognosis in Patients with Acute Myeloid Leukemia. (PubMed, J Investig Med)
As a conclusion increased serum GDF11 levels in AML patients may be linked to the regeneration ability of leukemic stem cells. There is a need for studies investigating GDF11 expression in myeloblasts.
Journal
|
CDH1 (Cadherin 1) • CD34 (CD34 molecule) • VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1)
|
CD34 positive
9ms
A case of superficial CD34 positive fibroblastic tumor: Diagnostic challenges and pitfalls. (PubMed, Indian J Pathol Microbiol)
A constellation of clinicoradiological profiles, IHC features, and sometimes molecular studies clinch the definitive diagnosis which can be helpful in avoiding overtreatment and chemotherapy. Here we highlight the diagnostic challenges and pitfalls in a case of SCPFT.
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
9ms
Angiosarcoma of the head and neck: A clinicopathologic study with special emphasis on diagnostic pitfalls. (PubMed, Indian J Pathol Microbiol)
Head and neck AS pose a significant diagnostic challenge due to their broad morphologic spectrum. Proper clinicopathologic correlation is necessary to avoid misdiagnosis.
Journal
|
CD34 (CD34 molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1)
|
CD34 positive
9ms
CD30 expression in an emerging group of mesenchymal spindle cell neoplasms with ALK fusion detected by flow cytometry and immunohistochemistry. (PubMed, Genes Chromosomes Cancer)
The patient showed significant tumor response to single-agent treatment with alectinib, an ALK-tyrosine kinase inhibitor...The benefit of the early detection of CD30 expression by FCM for a prompt diagnosis and treatment is highlighted in the context of an aggressive clinical course. This case represents a learning experience regarding the need to the check the status of CD30 expression in these tumors and suggests the potential clinical benefits of CD30-targeted therapy.
Journal
|
BRAF (B-raf proto-oncogene) • ALK (Anaplastic lymphoma kinase) • TNFRSF8 (TNF Receptor Superfamily Member 8) • CD34 (CD34 molecule) • NTRK (Neurotrophic receptor tyrosine kinase) • PLEKHH2 (Pleckstrin Homology, MyTH4 And FERM Domain Containing H2)
|
ALK rearrangement • ALK fusion • TNFRSF8 expression • CD34 positive • NTRK fusion
|
Alecensa (alectinib)
9ms
Myeloid sarcoma with RBM15::MRTFA (MKL1) mimicking vascular neoplasm. (PubMed, Virchows Arch)
Based on these findings, myeloid sarcoma/AML with RBM15::MRTFA(MKL1) fusion diagnosis was made. AML with RBM15::MRTFA(MKL1) fusion can initially present as extramedullary lesions and might cause misdiagnosis of non-hematologic malignancies.
Journal
|
CD34 (CD34 molecule) • ITGB3 (Integrin Subunit Beta 3) • MRTFA (Myocardin Related Transcription Factor A) • RBM15 (RNA Binding Motif Protein 15)
|
CD34 positive
9ms
Ultrastructural differences between synovial sarcoma and solitary fibrous tumor: comparative study in adult patients from the National Cancer Institute of Mexico. (PubMed, Ultrastruct Pathol)
Conversely, tandem junctions were not found in any SFT case. Although the presence of multivesicular buds in the SFT was not significant, it had not been previously described.
Journal
|
CD34 (CD34 molecule) • STAT6 (Signal transducer and activator of transcription 6)
|
CD34 positive
9ms
A Case of Recurrent Gastric GIST Who Survived for Long after Laparoscopic Resection and Imatinib Therapy (PubMed, Gan To Kagaku Ryoho)
The pattern of tumor recurrence noted in the present case(ie, metastasis/dissemination to the skeletal muscles)is relatively rare, and few reports have been published concerning long-term survivors through multidisciplinary treatment (surgical treatment and others). We report this case with a review of the literature.
Journal
|
CD34 (CD34 molecule)
|
KIT positive • CD34 positive
|
imatinib
10ms
Superficial CD34-Positive Fibroblastic Tumor. (PubMed, Surg Pathol Clin)
In this review, we summarize the current knowledge on this rare entity with a special focus on its clinicopathological features, morphologic spectrum, and differential diagnosis. We also provide data regarding recent discoveries on its molecular profile and discuss its prognosis and management.
Review • Journal
|
CD34 (CD34 molecule)
|
CD34 positive
10ms
GAS5 promotes cytarabine induced myelosuppression via inhibition of hematopoietic stem cell differentiation. (PubMed, Toxicol Appl Pharmacol)
In conclusion, our study highlights that GAS5 inhibited the in vitro proliferation and reduced the hematopoietic colony-forming ability of cord blood-derived CD34 cells, with the most pronounced effect observed on CFU-GEMM formation. GAS5 also enhanced the inhibitory effect of Ara-C on the in vitro hematopoietic ability of CD34 HSCs.
Journal
|
CD34 (CD34 molecule) • GATA1 (GATA Binding Protein 1) • GAS5 (Growth Arrest Specific 5)
|
CD34 positive
|
cytarabine
10ms
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
10ms
Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 mice. (PubMed, Vet Pathol)
The longer survival and decreased MCH phenotype severity in NOG-EXL mice enabled their use in a tumor xenotransplantation study. The NOG-EXL model is better suited than the NSG-SGM3 model for immuno-oncology studies requiring long-term survival after humanization.
Preclinical • Journal • IO biomarker
|
CD34 (CD34 molecule)
|
CD34 positive
11ms
Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels. (PubMed, Cureus)
Peripheral blood mononuclear cells, bone marrow mononuclear cells, and cluster of differentiation 34-positive (CD34+) cells were isolated and assessed for the chymotrypsin-like activity of the proteasome and β5 subunit accumulation...Both parameters were shown to be associated with transfusion dependency, since transfusion-dependent patients (n=5 in each subgroup) had decreased proteasome activity and simultaneously exhibited higher ROS levels. Our results indicate that reduced β5 expression might potentially explain PIs' ineffectiveness in lower-risk MDS, elucidating the importance of the risk group in the selection of the proper treatment algorithm.
Journal
|
CD34 (CD34 molecule)
|
CD34 positive
|
bortezomib